Cardinal Health, Inc.

CAH

US14149Y1082

Pharmaceuticals

Real-time Estimate Cboe BZX Other stock markets 09:56:32 2024-06-10 am EDT			5-day change	1st Jan Change
97.6 ^USD	-0.93%		-2.19%	-3.44%

Jun. 08	Top law firms in US opioid lawsuits to get hundreds of millions in fees	RE
May. 29	Transcript : Cardinal Health, Inc. Presents at 2024 Leerink Partners Healthcare Crossroads Conference, May-29-2024 08:00 AM

Cardinal Health, Inc. announces an Equity Buyback for $3,000 million worth of its shares.

November 09, 2021 at 07:01 am EST

Cardinal Health, Inc. (NYSE:CAH) announces a share repurchase program. Under the program, the company will repurchase up to $3,000 million worth of its common stock. The program will expire on December 31, 2024.

Latest news about Cardinal Health, Inc.

Top law firms in US opioid lawsuits to get hundreds of millions in fees	Jun. 07	RE
Transcript : Cardinal Health, Inc. Presents at 2024 Leerink Partners Healthcare Crossroads Conference, May-29-2024 08:00 AM	May. 29
Baird Adjusts Price Target on Cardinal Health to $129 From $128	May. 29	MT
JPMorgan Adjusts Cardinal Health Price Target to $111 From $119	May. 17	MT
Argus Adjusts Price Target on Cardinal Health to $115 From $120	May. 15	MT
Transcript : Cardinal Health, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 08:00 AM	May. 14
Cardinal Health Board of Directors Approves Increase to Quarterly Dividend, Payable on July 15, 2024	May. 07	CI
Deutsche Bank Adjusts Price Target on Cardinal Health to $110 From $116	May. 07	MT
Jefferies Cuts Cardinal Health's Price Target to $105 From $110	May. 06	MT
Wells Fargo Raises Cardinal Health's Price Target to $95 From $94	May. 03	MT
Baird Adjusts Price Target on Cardinal Health to $128 From $134	May. 03	MT
Leerink Partners Adjusts Cardinal Health Price Target to $120 From $118	May. 02	MT
Transcript : Cardinal Health, Inc., Q3 2024 Earnings Call, May 02, 2024	May. 02
Cardinal Health Posts Higher Fiscal Q3 Non-GAAP Earnings, Revenue; Raises Fiscal 2024 Earnings Guidance	May. 02	MT
Earnings Flash (CAH) CARDINAL HEALTH Reports Q3 Revenue $54.91B, vs. Street Est of $56.11B	May. 02	MT
Earnings Flash (CAH) CARDINAL HEALTH Posts Q3 EPS $2.08, vs. Street Est of $1.95	May. 02	MT
Cardinal Health, Inc. Provides Preliminary Earnings Guidance for Fiscal Year 2025	May. 02	CI
Cardinal Health, Inc. Raises Its Earnings Guidance for Fiscal Year 2024	May. 02	CI
Cardinal Health, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	May. 02	CI
Cardinal Health, Inc. Reports Impairment Charges for the Third Quarter Ended March 31, 2024	May. 02	CI
Futures climb as Fed allays rate-hike worries	May. 02	RE
Wells Fargo Adjusts Cardinal Health Price Target to $94 From $96	Apr. 29	MT
US FDA sends warning to Cardinal Health for marketing unapproved devices	Apr. 25	RE
Evercore ISI Adjusts Cardinal Health's Price Target to $110 From $118, Keeps In Line Rating	Apr. 24	MT
Morgan Stanley Adjusts Cardinal Health's Price Target to $114 From $117, Maintains Overweight Rating	Apr. 23	MT

Chart Cardinal Health, Inc.

Duration

Period

More charts

Company Profile

Cardinal Health, Inc. is specialized in the distribution of products and health services to pharmacies, hospitals and medical practices. Net sales break down by activity as follows: - distribution of pharmaceutical products (92.7%); - distribution of medical, surgical and laboratory products (7.3%). The group also develops a manufacturing of medical and surgical products activity (masks, overalls, gloves, diagnostic products, products of aspiration and collection of liquids, radiology intervention, respiratory assistance, etc.). The United States accounts for 97.7% of net sales.

Sector

Pharmaceuticals

Calendar

2024-06-30 - Ex-dividend day

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Cardinal Health, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

98.51 USD

Average target price

111.9 USD

Spread / Average Target

+13.55%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
CARDINAL HEALTH, INC.	-3.44%	23.99B
MCKESSON CORPORATION	+26.41%	76.29B
SINOPHARM GROUP CO. LTD.	+10.27%	9.01B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+12.25%	8.67B
HUADONG MEDICINE CO., LTD	-24.34%	7.58B
H. LUNDBECK A/S	+12.70%	5.18B
GALENICA AG	+1.92%	4.16B
EBOS GROUP LIMITED	-4.96%	3.98B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	-1.36%	3.63B
CHINA NATIONAL MEDICINES CORPORATION LTD.	+20.13%	3.58B

Pharmaceuticals Wholesale